Literature DB >> 18806567

Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum.

Scott H Britz-Cunningham1, John W Millstine, Victor H Gerbaudo.   

Abstract

PURPOSE: This study demonstrates a simple background correction method, which improves the discrimination of benign from malignant lesions on FDG PET-CT imaging, using activity ratios compared with brain, basal ganglia, or cerebellum.
METHODS: Standardized uptake values (SUVs) and comparative activity ratios (CARs) were determined for FDG uptake in 92 lesions (39 benign and 53 malignant) in 49 patients. Reference tissues included cerebral cortex, basal ganglia, cerebellum, lung, liver, and aortic blood pool. Discriminant power for each CAR was evaluated as malignant-to-benign ratio of mean uptake and ratio of intermediate-likelihood lesions to total number of lesions.
RESULTS: Uncorrected SUV varied widely for malignant and benign lesions, with considerable overlap. Ratio of mean uptake for malignant lesions versus benign lesions was lowest for uncorrected SUVAVG and SUVAVG/liver (1.92), and highest for SUVMAX/cerebral cortex (3.52). Lesions could be separated into very high (> 90%), very low (< 10%), and intermediate (> or = 10% and < or = 90%) likelihood of malignancy. The ratio of intermediate-likelihood lesions to the total number of lesions was greatest for SUVAVG (0.42) and lowest for SUVMAX/basal ganglia (0.22).
CONCLUSIONS: Ability to discriminate malignant from benign lesions was enhanced by using CARs derived from cerebral cortex, basal ganglia, or cerebellum. Using a 3-tiered diagnostic schema, most lesions could be assigned to categories of very high or very low likelihood of malignancy, with a significant reduction in indeterminant lesions, compared with uncorrected SUV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806567     DOI: 10.1097/RLU.0b013e318184b435

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  11 in total

1.  Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis.

Authors:  Laura L Horky; Edward M Hsiao; Stephanie E Weiss; Jan Drappatz; Victor H Gerbaudo
Journal:  J Neurooncol       Date:  2010-09-14       Impact factor: 4.130

2.  Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging.

Authors:  Thomas Christen; Yuri Sheikine; Viviane Z Rocha; Shelley Hurwitz; Allison B Goldfine; Marcelo Di Carli; Peter Libby
Journal:  JACC Cardiovasc Imaging       Date:  2010-08

3.  Amygdalar activity predicts future incident diabetes independently of adiposity.

Authors:  Michael T Osborne; Amorina Ishai; Basma Hammad; Brian Tung; Ying Wang; Amos Baruch; Zahi A Fayad; Jon T Giles; Janet Lo; Lisa M Shin; Steven K Grinspoon; Karestan C Koenen; Roger K Pitman; Ahmed Tawakol
Journal:  Psychoneuroendocrinology       Date:  2018-09-22       Impact factor: 4.905

4.  Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings.

Authors:  Virendra Kumar; Kavindra Nath; Claudia G Berman; Jongphil Kim; Tawee Tanvetyanon; Alberto A Chiappori; Robert A Gatenby; Robert J Gillies; Edward A Eikman
Journal:  Clin Nucl Med       Date:  2013-03       Impact factor: 7.794

5.  Glucose corrected standardized uptake value (SUVgluc) in the evaluation of brain lesions with 18F-FDG PET.

Authors:  Asae Nozawa; Ali Hosseini Rivandi; Santosh Kesari; Carl K Hoh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-10       Impact factor: 9.236

6.  Greater Neurobiological Resilience to Chronic Socioeconomic or Environmental Stressors Associates With Lower Risk for Cardiovascular Disease Events.

Authors:  Tawseef Dar; Michael T Osborne; Shady Abohashem; Taimur Abbasi; Karmel W Choi; Ahmed Ghoneem; Nicki Naddaf; Jordan W Smoller; Roger K Pitman; John W Denninger; Lisa M Shin; Gregory Fricchione; Ahmed Tawakol
Journal:  Circ Cardiovasc Imaging       Date:  2020-08-13       Impact factor: 7.792

7.  Stress-associated neurobiological activity associates with the risk for and timing of subsequent Takotsubo syndrome.

Authors:  Azar Radfar; Shady Abohashem; Michael T Osborne; Ying Wang; Tawseef Dar; Malek Z O Hassan; Ahmed Ghoneem; Nicki Naddaf; Tomas Patrich; Taimur Abbasi; Hadil Zureigat; James Jaffer; Parastou Ghazi; James A Scott; Lisa M Shin; Roger K Pitman; Tomas G Neilan; Malissa J Wood; Ahmed Tawakol
Journal:  Eur Heart J       Date:  2021-05-14       Impact factor: 35.855

8.  Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.

Authors:  Asae Nozawa; Ali Hosseini Rivandi; Masayuki Kanematsu; Hiroaki Hoshi; David Piccioni; Santosh Kesari; Carl K Hoh
Journal:  Nucl Med Commun       Date:  2015-06       Impact factor: 1.690

9.  18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.

Authors:  Mohammed Shah Alam; Lilan Fu; Yun-Yan Ren; Hu-Bing Wu; Quan-Shi Wang; Yan-Jiang Han; Wen-Lan Zhou; Hong-Sheng Li; Zhen Wang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

10.  Early detection of cerebral glucose uptake changes in the 5XFAD mouse.

Authors:  I R Macdonald; D R DeBay; G A Reid; T P O'Leary; C T Jollymore; G Mawko; S Burrell; E Martin; C V Bowen; R E Brown; S Darvesh
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.